戻る Agenda
Asia-2b : Transformation in Quality Management Approach for Global Clinical Trials - Strategic E6(R3) Implementation to Realize “Flexible" GCP Leveraging CTQ Factors
Session Chair(s)
Izumi Oba
Inspection Deupty Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Nayoung Lee, MBA
Vice president, Commercial APAC, PAREXEL, Korea, Republic of
Osamu Komiyama
CEO, Office Komiyama, Japan
Yang Zhao
Professor of Biostatistics, Director of the Office of Clinical Research, Nanjing Medical University, of the Department of Biostatistics, China
Bokjin Hyun
Executive Director, Head of Clinical Research, HANDOK, Korea, Republic of
Rebecca Stanbrook, RPh
EFPIA ICH E6(R3) Expert Working Group Member, RESaltas GmbH, Switzerland